Market Overview:
The global LMWH products market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of thromboembolic disorders, rising geriatric population, and technological advancements in the field of LMWH products. The global LMWH products market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into enoxaparin, dalteparin, tinzaparin, and fraxiparine. Enoxaparin dominates this market owing to its high efficacy and safety profile as compared to other types of LMWHs available in the market. On the basis of application, medical accounts for a major share owing to its widespread use for prophylaxis and treatment purposes across various medical specialties such as cardiology & vascular surgery; general surgery; neurology & neurosurgery; oncology; orthopedics & rheumatology; pediatric surgery; urology & nephrology etc.
Product Definition:
Low molecular weight heparin (LMWH) products are anticoagulant medications used to prevent and treat blood clots. LMWHs are given as injections, typically under the skin. They work by preventing the formation of new clots and breaking up existing clots.
Enoxaparin:
Enoxaparin is a low molecular weight heparin drug developed by Bayer in the early 70s. It was approved for treatment of deep vein thrombosis and pulmonary embolism in Europe and Japan, but not in the U.S., due to its poor pharmacological properties compared to warfarin.
However, it has recently gained popularity as an LMWH product owing to its better safety.
Dalteparin:
Dalteparin is a synthetic, semi-synthetic, or natural anticoagulant used in the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT usually affects the passengers traveling by plane and results in swelling of legs and feet due to blood clot formation. Dalteparin is used as an anticoagulant drug for prevention from DVT during medical procedures such as surgery.
Application Insights:
Medical application of LMWH accounted for the largest share in 2017. The growing geriatric population and increasing cases of cardiovascular diseases are the major factors driving this segment. As per WHO, in 2016, cardiovascular diseases were responsible for around 31% of deaths globally; this number is expected to increase to 32% by 2030 if no corrective measures are taken. Therefore, companies focusing on developing innovative products with better therapeutic benefits is expected to drive product demand over the forecast period.
The research application segment is projected register a significant CAGR during the forecast period owing to rising R&D investments by various organizations and governments across countries such as U.S., China and India regarding heart disease treatment options & prevention methods.
Regional Analysis:
North America dominated the global market in 2017 owing to the high prevalence of cardiovascular diseases and increasing per capita healthcare expenditure. The region is expected to maintain its dominance over the forecast period due to factors such as favorable reimbursement policies, rising geriatric population, and technological advancements.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rapid economic development coupled with an increase in disposable income levels. Furthermore, a rise in cardiovascular disease prevalence rates will also drive regional growth during this period. Increasing investments by major players for manufacturing & distribution expansion are projected to further fuel industry expansion over next eight years (2018-2030). For instance, Novo Nordisk has been expanding its operations across Asia Pacific since 2015 for promoting LMWHs through various initiatives such as partnerships with local distributors and manufacturers or mergers & acquisitions of local companies that manufacture generic drugs & medical devices (bandages).
Growth Factors:
- Increasing incidence of venous thromboembolism (VTE) and pulmonary embolism (PE)
- Growing geriatric population susceptible to VTE and PE
- Rising demand for prophylactic anticoagulants in surgeries and other medical procedures
- Technological advancements in LMWH products that improve their safety profile
- Launch of novel LMWH products with better efficacy and safety profiles
Scope Of The Report
Report Attributes
Report Details
Report Title
LMWH Products Market Research Report
By Type
Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine
By Application
Medical, Research
By Companies
Sanofi-aventis, Aspen, Sandoz, Pfizer, Opocrin, Leo, CSBIO, Dongying Tiandong Pharmaceutica, Changzhou Qianhong Bio-pharma, Yantai Dongcheng Pharmaceutical Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global LMWH Products Market Report Segments:
The global LMWH Products market is segmented on the basis of:
Types
Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical, Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi-aventis
- Aspen
- Sandoz
- Pfizer
- Opocrin
- Leo
- CSBIO
- Dongying Tiandong Pharmaceutica
- Changzhou Qianhong Bio-pharma
- Yantai Dongcheng Pharmaceutical Group
Highlights of The LMWH Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Enoxaparin
- Dalteparin
- Tinzaparin
- Fraxiparine
- By Application:
- Medical
- Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the LMWH Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
LMWH products are a type of medication that helps to prevent blood clots. They work by breaking down the blood clotting proteins and preventing them from forming.
Some of the major players in the lmwh products market are Sanofi-aventis, Aspen, Sandoz, Pfizer, Opocrin, Leo, CSBIO, Dongying Tiandong Pharmaceutica, Changzhou Qianhong Bio-pharma, Yantai Dongcheng Pharmaceutical Group.
The lmwh products market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. LMWH Products Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. LMWH Products Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. LMWH Products Market - Supply Chain
4.5. Global LMWH Products Market Forecast
4.5.1. LMWH Products Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. LMWH Products Market Size (000 Units) and Y-o-Y Growth
4.5.3. LMWH Products Market Absolute $ Opportunity
5. Global LMWH Products Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. LMWH Products Market Size and Volume Forecast by Type
5.3.1. Enoxaparin
5.3.2. Dalteparin
5.3.3. Tinzaparin
5.3.4. Fraxiparine
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global LMWH Products Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. LMWH Products Market Size and Volume Forecast by Application
6.3.1. Medical
6.3.2. Research
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global LMWH Products Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. LMWH Products Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global LMWH Products Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. LMWH Products Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global LMWH Products Demand Share Forecast, 2019-2026
9. North America LMWH Products Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America LMWH Products Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America LMWH Products Market Size and Volume Forecast by Application
9.4.1. Medical
9.4.2. Research
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America LMWH Products Market Size and Volume Forecast by Type
9.7.1. Enoxaparin
9.7.2. Dalteparin
9.7.3. Tinzaparin
9.7.4. Fraxiparine
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America LMWH Products Demand Share Forecast, 2019-2026
10. Latin America LMWH Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America LMWH Products Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America LMWH Products Market Size and Volume Forecast by Application
10.4.1. Medical
10.4.2. Research
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America LMWH Products Market Size and Volume Forecast by Type
10.7.1. Enoxaparin
10.7.2. Dalteparin
10.7.3. Tinzaparin
10.7.4. Fraxiparine
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America LMWH Products Demand Share Forecast, 2019-2026
11. Europe LMWH Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe LMWH Products Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe LMWH Products Market Size and Volume Forecast by Application
11.4.1. Medical
11.4.2. Research
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe LMWH Products Market Size and Volume Forecast by Type
11.7.1. Enoxaparin
11.7.2. Dalteparin
11.7.3. Tinzaparin
11.7.4. Fraxiparine
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1 By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe LMWH Products Demand Share, 2019-2026
12. Asia Pacific LMWH Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific LMWH Products Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific LMWH Products Market Size and Volume Forecast by Application
12.4.1. Medical
12.4.2. Research
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific LMWH Products Market Size and Volume Forecast by Type
12.7.1. Enoxaparin
12.7.2. Dalteparin
12.7.3. Tinzaparin
12.7.4. Fraxiparine
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific LMWH Products Demand Share, 2019-2026
13. Middle East & Africa LMWH Products Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa LMWH Products Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa LMWH Products Market Size and Volume Forecast by Application
13.4.1. Medical
13.4.2. Research
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa LMWH Products Market Size and Volume Forecast by Type
13.7.1. Enoxaparin
13.7.2. Dalteparin
13.7.3. Tinzaparin
13.7.4. Fraxiparine
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa LMWH Products Demand Share, 2019-2026
14. Competition Landscape
14.1. Global LMWH Products Market: Market Share Analysis
14.2. LMWH Products Distributors and Customers
14.3. LMWH Products Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sanofi-aventis
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Aspen
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sandoz
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Pfizer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Opocrin
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Leo
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. CSBIO
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Dongying Tiandong Pharmaceutica
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Changzhou Qianhong Bio-pharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Yantai Dongcheng Pharmaceutical Group
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
